In the context in which we did not consider the type of treatment and groups, it can be said that the improvements in BMI, ALT and AP were specific to another specific common feature common of the group, which responded to the treatment and which can be represented by obesity. Here, GPT is linked to obesity due to melanocortin 4 receptor deficiency.